Welcome to our dedicated page for Marchex SEC filings (Ticker: MCHX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Investors tracking how Marchex monetizes conversational analytics often type natural questions like “Where can I find Marchex’s quarterly earnings report 10-Q filing?” or “Are Marchex SEC filings explained simply anywhere?” You’ll find both answers here. Stock Titan opens each document seconds after it appears on EDGAR and pairs it with an AI-driven summary, so you can jump straight to voice-analytics revenue, customer churn, or paid-media attribution metrics without scanning hundreds of pages.
Use our platform to follow Marchex insider trading Form 4 transactions or set alerts for Marchex Form 4 insider transactions real-time. Our AI surfaces key numbers and red-flag language, giving you the Marchex earnings report filing analysis that matters. Need help understanding Marchex SEC documents with AI? One click delivers plain-English guidance on liquidity, SaaS ARR trends, and goodwill impairments, plus side-by-side views of prior 10-Ks. Annual reports are no longer a slog; you get each Marchex annual report 10-K simplified alongside fresh benchmarks.
Looking into management incentives? The dedicated section on Marchex executive stock transactions Form 4 and every Marchex proxy statement executive compensation table makes cross-check seamless. For sudden developments, our dashboard lists each Marchex 8-K material events explained in everyday language, from leadership changes to major customer losses. Because we host every form—10-Q, 10-K, 8-K, S-8, and more—with real-time updates, AI-powered summaries, and expert commentary, you can move from data to decision faster than a sales call converts. Complex voice-analytics business, simple disclosures.
Francis J. Feeney, Chief Operating Officer of Marchex, Inc. (MCHX), filed a Form 3 disclosing his initial beneficial ownership. The filing reports 277,428 shares of Class B common stock held directly and a portfolio of equity awards that could convert to additional shares.
The derivative holdings include employee stock options to purchase 848,000 shares with exercise prices ranging from $1.45 to $5.05 and expiration dates between 2028 and 2034, plus 62,500 restricted stock units that vest in full on the first anniversary of their March 20, 2025 grant. All reported holdings are direct and subject to specified vesting schedules tied to continued employment.
Marchex reported revenue of $11.655 million for the quarter ended June 30, 2025, down 3% from $12.074 million a year earlier, and $23.058 million for the six months, down 2% year over year. The company recorded a small quarterly net income of $85 thousand (basic and diluted EPS $0.00) after narrowing its operating loss, but posted a six-month net loss of $1.897 million (basic/diluted loss per share approximately $0.04). Cash and cash equivalents were $10.491 million, total assets $41.984 million, and accumulated deficit $328.075 million.
Operational highlights: sales and marketing expense increased while product development declined due to capitalization and reorganization; cost of revenue remained ~35% of revenue. The company recognized a ~$0.6 million gain from a domain sale, authorized a new repurchase program to buy up to 3,000,000 Class B shares (no repurchases made), and recorded a 100% valuation allowance against deferred tax assets. One customer accounted for ~11% of revenue and 21% of receivables, and litigation over a prior acquisition earnout is in discovery.
Marchex, Inc. announced it is issuing an earnings release and holding a conference call to report results for the quarter ended June 30, 2025. The full earnings release is furnished as Exhibit 99.1 to the Current Report. The company discloses it will present both GAAP and non-GAAP financial measures; the release includes reconciliations and definitions explaining why management believes the non-GAAP measures are useful to investors. The 8-K furnishes this information rather than treating it as formally "filed" under the Exchange Act.
FAQ
What is the current stock price of Marchex (MCHX)?
What is the market cap of Marchex (MCHX)?
